Stocks in play: BELLUS Health Inc.
Announced today that it has completed its previously-announced underwritten public offering in Canada and the United States of 25,000,000 common shares at a price to the public of US$8.00 per common share. The total gross proceeds to the Company were US$200 million. BELLUS Health Inc. shares T.BLU are trading down $0.23 at $9.96.
Read:
As Crypto Mining Undergoes a Sustainable Renaissance, Newer, Greener Operations Arise
Oncology Drug Developers Looking at Significant Projected Growth Through 2030
Plant-Based Meats Continue to Sprout Growing Revenues on Year-Over-Year Basis
No Apparent Need to Panic Over Omicron as Vaccine Developers Are on the Case
Plant-Based Meats Market Projected to Hit $162 Billion by 2030, as New Products Launch